All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
| Status | Trial ID | Title | Completion date | Category |
|---|---|---|---|---|
| Reported results | 2004-001888-21 | A cross-over comparative study of inhaled mannitol, alone and in combination with daily rhDNase, in children with cystic fibrosis | 2007-11-15 | due-trials |
| Reported results | 2005-005452-41 | A phase III Multicenter, randomised, parallel, placebo-controlled, double-blind study to investigate the safety and efficacy of treatment with Bronchitol (dry powder mannitol) in the symptomatic treat... | 2008-06-05 | due-trials |
| Reported results Terminated | 2006-004078-28 | Long Term Administration of Inhaled Dry Powder Mannitol In Cystic Fibrosis – A Safety and Efficacy Study | 2007-03-05 | due-trials |
| Reported results | 2007-001412-23 | Long Term Administration of Inhaled Dry Powder Mannitol In Cystic Fibrosis – A Safety and Efficacy Study | 2010-03-26 | due-trials |
| Reported results Terminated | 2008-002644-42 | A phase III multicenter, randomized, parallel, controlled, double blind study to investigate the safety and efficacy of inhaled mannitol over 12 months in the treatment of bronchiectasis | 2008-12-19 | due-trials |
| Reported results | 2008-002740-42 | Long Term Administration of Inahled Mannitol in Cystic Fibrosis - A Safety and Efficacy Study | 2010-10-25 | due-trials |
| Exempt, with results | 2008-008228-34 | Determination of the pharmacokinetics of inhaled mannitol after single and multiple dosing in cystic fibrosis patients | 2009-12-08 | not-yet-due |
| Reported results | 2008-008731-28 | A phase III multicenter, randomized, parallel, controlled, double blind study to investigate the safety and efficacy of inhaled mannitol over 12 months in the treatment of bronchiectasis. | 2013-02-28 | due-trials |
| Reported results Terminated | 2011-000126-30 | A phase II, multi-centre, single blind study to evaluate the safety, tolerability and explore the efficacy of 8.0 mg ASM8 inhaled daily for 14 days in adult subjects with moderate to severe asthma | 2011-12-08 | due-trials |
| Reported results | 2012-002699-14 | A randomised, multicentre, double-blind, placebo-controlled, crossover trial determining the efficacy of dry powder mannitol in improving lung function in subjects with Cystic Fibrosis aged six to sev... | 2015-10-02 | due-trials |
| Reported results | 2013-005357-79 | Long Term Administration of Inhaled Mannitol in Cystic Fibrosis – A Safety and Efficacy Trial in Adult Cystic Fibrosis Subjects | 2017-02-21 | due-trials |